K903531

Substantially Equivalent

ANTICARDIOLIPIN ANTIBODY TEST SYSTEM

Applicant: Medical Innovations Corp.
Product code: GFO
Advisory panel: Hematology
Date received: 1990-08-06
Decision date: 1991-01-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Portland, OR, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.